European health systems and cancer care

Micheli, Andrea; Coebergh, Jan Willem; Mugno, E.; Massimiliani, Erika; Sant, Milena; Oberaigner, Willi; Holub, Jiří; Storm, Hans H.; Forman, David; Quinn, Mike; Aareleid, Tiiu; Sankila, Risto; Hakulinen, Timo; Faivre, Jean; Ziegler, H; Tryggvadóttír, Laufey; Zanetti, Roberto; Dalmas, Miriam; Visser, Otto; Langmark, Frøydis; Bielska–Lasota, Magdalena; Wronkowski, Z; Pinheiro, Paulo Sérgio; Brewster, David H.; Pleško, I; Pompe-Kirn, Vera; Martínez‐García, Carmen; Barlow, Lotti; Möller, Torgil; Lutz, Jean Michel; André, M; Steward, John

doi:10.1093/annonc/mdg753

Cited by 126 publications

(63 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Even within Europe, standards of care differ greatly between countries and variation in cancer survival has been associated with national wealth, investments in health technology and education. (35)(36)(37) In this study, in general we saw that in countries with higher HDI levels the proportion of new cancer cases was equal or greater than the proportion of cancer deaths from all included cancer sites.…”

Section: This Is the First Investigation And Visual Representation Ofmentioning

confidence: 58%

Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century

Arnold

Rentería

Conway

et al. 2016

Cancer Causes Control

View full text Add to dashboard Cite

(250 words)Purpose: Inequalities in the burden of cancer have been well-documented and a variety of measures exist to analyse disease disparities. While previous studies have focused on inequalities within countries, the aim of the present study was to quantify existing inequalities in cancer incidence and mortality between countries.Methods: Data on total and site-specific cancer incidence and mortality in [2003][2004][2005][2006][2007] were obtained for 43 countries with medium to high levels of human development via Cancer Incidence in Five Continents Vol. X and the WHO Mortality Database. We calculated the concentration index as a summary measure of socioeconomic-related inequality between countries.Results: Inequalities in cancer burden differed markedly by site; the concentration index for all sites combined was 0.03 for incidence and 0.02 for mortality, pointing towards a slightly higher burden in countries with higher levels of the Human Development Index (HDI). For both incidence and mortality, this pattern was most pronounced for melanoma. In contrast, the burden of cervical cancer was disproportionally high in countries with lower HDI levels. Prostate, lung and breast cancer contributed most to inequalities in overall cancer incidence in countries with higher HDI levels, while for mortality these were mostly driven by lung cancer in higher HDI countries and stomach cancer in countries with lower HDI levels. Conclusion:Global inequalities in the burden of cancer remain evident at the beginning of the 21 st century:with a disproportionate burden of lifestyle-related cancers in countries classified as high HDI, while infectionrelated cancers continue to predominate in transitioning countries with lower levels of HDI.

show abstract

Section: This Is the First Investigation And Visual Representation Ofmentioning

confidence: 58%

Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century

Arnold

Rentería

Conway

et al. 2016

Cancer Causes Control

View full text Add to dashboard Cite

show abstract

“…A report from Statistics Sweden in 1999 estimated 4 to 8% ''over coverage'' in the Swedish population register for non-Nordic immigrants, while the Nordic countries have coordinated their population changes since 1969. 16 Moreover, because of the high-quality health care system and health insurance in Sweden, 17 a cancer patient might prefer to return to Sweden if she is still a registered citizen. Therefore, we consider the ''over coverage'' an unlikely explanation for our findings.…”

Section: Discussionmentioning

confidence: 99%

Risk of cervical cancer among immigrants by age at immigration and follow‐up time in Sweden, from 1968 to 2004

Azerkan

Zendehdel

Tillgren

et al. 2008

Intl Journal of Cancer

View full text Add to dashboard Cite

Because of great variation in the prevalence of human papilloma virus infection and other risk factors of cervical cancer worldwide, migrant studies may help further the understanding of the aetiology and improve prevention of cervical cancer. Our aim was to study the risk of invasive cervical cancer among immigrant women. We followed 758,002 immigrants from different countries who resided in Sweden between 1968 and 2004. Age-standardised incidence rates (ASRs) of immigrants were compared with that in their countries of origin. Poisson regression models estimated the relative risks of cervical cancer among immigrants, overall and stratified by age at migration and follow-up time, compared to Swedish-born women. Overall 1,991 of 19,542 observed cases of cervical cancer occurred among immigrants. Generally they had lower ASRs than in their countries of origin, with the exception of Nordic immigrants. Compared to Swedish-born women, we observed a higher relative risk of cervical cancer among immigrants overall (RR 5 1.13, 95% CI 1.08-1.18), and particularly among women from Denmark (RR 5 1.8, 95% CI 1.6-2.1), Norway (RR 5 1.7, 95% CI 1.5-1.9) and Central America (RR 5 2.5, 95% CI 1.3-4.9), while the relative risks were lower in immigrants from Eastern Africa (RR 5 0.2, 95% CI 0.1-0.6), South Central Asia (RR 5 0.4, 95% CI 0.2-0.6) and South Western Asia (RR 5 0.5, 95% CI 0.4-0.7). Follow-up time and age at migration were important effect modifiers for cervical cancer risks. We suggest targeted prevention toward high-risk immigrants, specifically older women, in the first 10 years after arrival into their new homeland.

show abstract

“…Expected survival rate is the survival rate in a population without the disease. The analysis of relative survival rate is generally used in population-based cancer registries (11)(12)(13). Relative survival analytic methods are often used to analyze aging-related disease to overcome the potential bias associated with age (14).…”

Section: Introductionmentioning

confidence: 99%

Relationship between survival and age in patients with idiopathic pulmonary fibrosis

Koo

Uh²,

Kim

et al. 2016

J. Thorac. Dis.

View full text Add to dashboard Cite

Background: There is a debate that older patients with idiopathic pulmonary fibrosis (IPF) have a worse prognosis. We evaluated whether age affects the survival of patients with IPF. Methods:The Korean Interstitial Lung Disease (ILD) Research Group conducted a national survey to evaluate the clinical, physiological, radiological, and survival characteristics of patients with IPF. A total of 1,663 patients with IPF were stratified into three groups according to age: (I) <60 years (n=309); (II) 60-69 years (n=613); and (III) ≥70 years (n=741).Results: The 1-, 3-and 5-year observed survival rates were 83.0%, 62.6%, and 49.2% in the total population, respectively. The 1-, 3-, and 5-year relative survival rates were 85.7%, 69.1%, and 58.0% in all patients, respectively. The observed survival rate of the group ≥70 years of age was significantly lower than those of the other groups (P<0.001). In contrast, no significant difference in relative survival rate was detected among the three age groups. Compared with patients less than 60 years of age, patients with above 70 years of age had not increased risk of worse relative survival [P=0.252; hazard ratio (HR), 1.11; 95% confidence interval (CI), 0.76-1.64]. Conclusions:The prognosis of patients above 70 years of age with IPF was not different to that of patients less than 60 years of age, using relative survival rate. Age may not affect survival in patients with IPF.

show abstract

European health systems and cancer care

Cited by 126 publications

References 8 publications

Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century

Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century

Risk of cervical cancer among immigrants by age at immigration and follow‐up time in Sweden, from 1968 to 2004

Relationship between survival and age in patients with idiopathic pulmonary fibrosis

Contact Info

Product

Resources

About